Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.

Giorgio Minotti, Raffaella Ronchi, Emanuela Salvatorelli, +2

PubMed

Iron MetabolismCardiovascular ToxicityDox MetabolismRedox BiologyOxidative Stress +16

Mild exercise training, cardioprotection and stress genes profile

Marina Marini, Rosa Lapalombella, V. Margonato, +8

European Journal of Applied Physiology

Physical ActivityKinesiologyExerciseExercise PhysiologyPhysiology +6

Nitric Oxide and Peroxynitrite Activate the Iron Regulatory Protein-1 of J774A.1 Macrophages by Direct Disassembly of the Fe−S Cluster of Cytoplasmic Aconitase

Gaetano Cairo, Raffaella Ronchi, Stefania Recalcati, +2

Biochemistry

Chronic in vivo hypoxia in various organs: Hypoxia-inducible factor-1α and apoptosis

Paola Bianciardi, Monica Fantacci, Anna Caretti, +6

Biochemical and Biophysical Research Communications

Various OrgansPhysiologyApoptosisHypoxia (Medicine)Cell Death +7

Phosphodiesterase-5 Inhibition Abolishes Neuron Apoptosis Induced by Chronic Hypoxia Independently of Hypoxia-Inducible Factor-1α Signaling

Anna Caretti, Paola Bianciardi, Raffaella Ronchi, +3

Experimental Biology and Medicine

Chronic systemic hypoxia promotes LNCaP prostate cancer growth in vivo

Laura Terraneo, Paola Bianciardi, Anna Caretti, +2

The Prostate

Pharmacological profile of a new anti-lipolytic agent: 5-methyl-pyrazine-2-carboxylic acid 4-oxide (acipimox) I — Mechanism of action

Pier Paolo Lovisolo, G Briatico-Vangosa, Giovanna Orsini, +3

Pharmacological Research Communications

Molecular PharmacologyNew Anti-lipolytic AgentBiochemistryMedicineMechanism Of Action +6

Myocardial tolerance to ischemia–reperfusion injury, training intensity and cessation

Fabio Esposito, Raffaella Ronchi, Giuseppina Milano, +5

European Journal of Applied Physiology

Ischemia–reperfusion InjuryCardiovascular DiseaseMyocardial InfarctionExercise PhysiologyApplied Physiology +3

Heart HIF-1alpha and MAP kinases during hypoxia: are they associated in vivo?

Anna Caretti, Sandrine Morel, Giuseppina Milano, +6

PubMed

Cardiac MuscleHeart Failure23-Hr HypoxiaCardiovascular FunctionRedox Biology +18

Pharmacological profile of a new antilipolytic agent: 5-methyl-pyrazine-2-carboxylic acid 4-oxide (acipimox) II — Antilipolytic and blood lipid lowering activity

Pier Paolo Lovisolo, G Briatico-Vangosa, Giovanna Orsini, +2

Pharmacological Research Communications

BiochemistryPharmacologyPharmacological AgentPharmacotherapyLipoprotein Metabolism +4